Brian W. Carlin, MD, FCCP, MAACVPR, FAARC

Brian W. Carlin, MD, FCCP, MAACVPR, FAARC

Brian W. Carlin, MD, is an assistant professor of medicine at Drexel University School of Medicine and is a senior staff physician at Allegheny General Hospital in Pittsburgh, Pennsylvania.  He received his undergraduate degree at Grove City College in Pennsylvania and his medical degree at Penn State University.  He completed his fellowship in pulmonary and critical care medicine at the University of California, San Diego.  He is in the private practice of pulmonary, critical care, and sleep medicine in Pittsburgh. 

Dr. Carlin has been a member of the ATS since 1988 and is a member of the Pulmonary Rehabilitation Assembly for which he is the program planning chair.  He is the chair of the Training and Transitions Committee.  Dr. Carlin is a past president of the American Association of Cardiovascular and Pulmonary Rehabilitation and is a member of the annual program planning committee and the document oversight committee for that organization.

He has also been actively involved in the American College of Chest Physicians.  He is a past member of the Health Science and Policy Committee and the Training and Transitions Committee.   He was the annual meeting program chairperson for the 2007 CHEST meeting.  He is the current vice chair for the education committee.  In addition, he is a member of the board for the National Board for Respiratory Care (the testing organization responsible for the development of certification for respiratory therapists).

Dr. Carlin has an interest in the early detection and management of patients with COPD.  He remains actively involved at both the national and local levels with early detection efforts and pulmonary rehabilitation. He is the current chair for the National Lung Health Education Program and is the immediate past chair for the COPD Alliance.  He is the current medical director for Lifeline Pulmonary Rehabilitation Therapy in Pittsburgh.  His current interests also include the development of programs to help reduce the thirty day rehospitalization rates for patients who have COPD exacerbation.

CME Courses

Pulmonology Symposium

This symposium will discuss Alpha-1-antitrypsin deficiency (AAT) and Pulmonary hypertension. AAT is an underrecognized genetic condition affecting approximately 1 in 2000 to 1 in 5000 individuals and predisposes to liver disease and early onset emphysema. Pulmonary hypertension is pathophysiological and hemodynamic state associated with several clinical conditions that can lead to progressive right ventricular failure and death.

Publish Date: 08/24/2012
Number of Videos: 2